Skip to content
To the full analysis

Novo Nordisk stock: balance sheet and debt

NOVO-B.CO
$40.88Closing price of 12 Nov 2026MEQIRI Score 79 out of 100

Novo Nordisk has a debt to equity ratio of 0.67 and an interest coverage of 19.9x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.67
Interest coverage
19.9x
Current ratio
0.8
Cash & equivalents
$4B
Total assets
$80.48B
Equity ratio
35.7%
Goodwill
$2.94B
Plus intangible assets of $16.34B
Net debt
$15.42B

Total assets and equity ratio

How large the balance sheet of Novo Nordisk A/S is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$6.63B$94.65M$2.51M67.4%−$531.88M
2007$7.08B$99.31M$9.85M67.4%−$892.24M
2008$7.52B$117.35Mnot split out65.2%−$1.17B
2009$8.11B$153.72Mnot split out65.3%−$1.7B
2010$9.1B$216.12M$10.38M60.2%−$2.05B
2011$9.59B$220.72Mnot split out57.9%−$2.47B
2012$9.73B$221.61Mnot split out61.9%−$2.31B
2013$10.43B$239.4Mnot split out60.5%−$2.11B
2014$11.42B$204.26Mnot split out52.3%−$2.25B
2015$13.61B$319.89Mnot split out51.2%−$2.87B
2016$14.46B$402.3Mnot split out46.4%−$3.03B
2017$15.17B$492.87Mnot split out48.7%−$2.54B
2018$16.42B$762.66Mnot split out46.8%−$2.24B
2019$18.62B$864.94Mnot split out45.8%−$1.63B
2020$21.48B$3.06Bnot split out43.7%−$355.91M
2021$28.83B$6.4B$644.22M36.4%$1.36B
2022$35.76B$7.62B$754.8M34.6%$327.59M
2023$46.62B$8.95B$661.71M33.9%−$477.9M
2024$69.05B$16.47B$2.97B30.8%$11.34B
2025$80.48B$19.28B$2.94B35.7%$15.42B

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$756.36M$4.47B$224.48M0.05
2007$1.09B$4.78B$202.4M0.04
2008$1.51B$4.9B$344.13M0.07
2009$1.9B$5.3B$205.75M0.04
2010$2.38B$5.48B$329.67M0.06
2011$2.59B$5.55B$126.44M0.02
2012$2.39B$6.02B$74.12M0.01
2013$2.14B$6.31B$31.87M0.01
2014$2.36B$5.97B$106.73M0.02
2015$3.03B$6.96B$159.05M0.02
2016$3.07B$6.71B$33.95M0.01
2017$2.79B$7.38B$251.11M0.03
2018$2.32B$7.68B$76.34M0.01
2019$2.29B$8.54B$664.53M0.08
2020$1.89B$9.39B$1.54B0.16
2021$2.59B$10.49B$3.95B0.38
2022$3.49B$12.38B$3.82B0.31
2023$4.48B$15.8B$4B0.25
2024$3.9B$21.27B$15.24B0.72
2025$4B$28.76B$19.41B0.67

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = DKK 6.7461)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 31 Oct 2006)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy